Nita J Maihle PhD
Professor of Obstetrics, Gynecology, and Reproductive Sciences, of Pathology and of Pharmacology; Director, Biology of Reproductive Tract Cancers Program
1)Discovery and application of disruptive innovations to improve the detection, treatment, and prevention of cancer.
2) ‘Precision medicine’ in oncology -- the coupling of early detection and theragnostic biomarkers with the treatment of patients using biologically-targeted therapeutics.
3) Use of “soluble” EGFR/HER receptors (sEGFR and sHERs) as novel serum/tissue biomarkers and also as potential biotherapeutics for the treatment of adult solid tumors.